New products, including those based on our increasing understanding of genomics and proteomics, are continually emerging as a direct result of accelerating scientific discovery. We help develop and manage these products throughout their life cycle, ensuring they're both commercially successful and comply with national and international regulations.

As life sciences companies mature, their legal requirements change.  From start-up to IPO and beyond we work with our clients to meet their business objectives.  Our life sciences team is multi-disciplinary and several members have advanced scientific qualifications and industry experience.  The members of the team understand both the technical and legal issues and keep abreast of developments in the sector.  Our support includes access to capital, mergers and acquisitions, structuring and negotiating licenses, collaborations and strategic partnerships, clinical development, regulatory issues, as well as the protection of intellectual property rights and patent and product liability litigation.

Our excellent track record has attracted a broad client base, including those operating in biotechnology, healthcare, pharmaceutical and medical devices.

• advising Phynova Group, Premier Research Group and Ondine Biopharma Corporation on admission to AIM
• advising Kowa Research Europe on its Phase III clinical trials
• advising Procognia on its licensing deals with Qiagen and Sigma Aldrich

Janita Good
t +44 (0)118 925 2146
janita.good@osborneclarke.com